Lung Cancer News

The addition of toripalimab to first-line chemotherapy prolonged PFS and OS among patients with advanced non-small cell lung cancer without EGFR/ALK mutations, according to study results.

Among survivors of nine common cancers, risk for CV death overtook cancer mortality for most cancer subtypes among patients aged at least 80 years, researchers reported.

Just as physicians became accustomed to wearing pagers 40 years ago or being tied to smartphones 2 decades ago, many have become active on social media as it entered their practices.

New cancer diagnosis appeared associated with increased risk for cardiovascular death, as well as incident heart failure, stroke or pulmonary embolism, according to a retrospective cohort study published in JACC: CardioOncology.

Obesity and elevated central adiposity were associated with increased risk for future cancers, including gastrointestinal and gynecologic cancer, researchers reported.

In a research collaboration with Mayo Clinic, nanomedical company NaNotics LLC plans to develop and assess a novel subtractive nanoparticle for use in cancer treatment.

Black Medicare beneficiaries who underwent elective cancer surgery had higher rates of mortality than their white counterparts, irrespective of neighborhood deprivation or dual eligibility status, according to study results.

Among individuals with certain cancers, treatment with radiotherapy was associated with poorer long-term CV-specific survival compared with those who did not undergo radiotherapy, researchers reported.

The FDA approved nivolumab with platinum doublet chemotherapy as neoadjuvant treatment for adults with resectable non-small cell lung cancer.

Cumulative exposure to high-dose angiotensin receptor blockers was associated with excess risk for cancer, according to a meta-regression analysis published in PLOS One.